Skip to content

Cerebral Arteriopathy With Subcortical Infarcts And Leukoencephalopathy C0751587

Published: July 22, 2026Updated: August 25, 2026

A condition causing progressive changes in brain blood vessels. It can affect younger individuals and may lead to repeated strokes. Management focuses on symptom control and stroke prevention.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hemiparesis

!

Severe headache

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Cognitive impairment

(neurologic)

Urinary incontinence

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Antiplatelet therapy

Low-dose aspirin or other antiplatelet agents may be recommended for stroke prevention in eligible patients with CADASIL. This approach aims to reduce the risk of recurrent ischemic events.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Blood pressure management

Aggressive control of hypertension through lifestyle modifications and antihypertensive medications to reduce vascular risk factors. Target blood pressure should be individualized based on overall cardiovascular risk.

lifestyle

Additional treatment options

Regular MRI surveillance

Periodic magnetic resonance imaging to monitor disease progression, white matter changes, and detect new ischemic lesions or microbleeds.

monitoring

Rehabilitation therapy

Physical, occupational, and speech therapy to address motor deficits, improve balance, and manage spasticity following stroke events.

physical_therapy

Neuropsychological support

Cognitive rehabilitation and psychological counseling to address cognitive decline, depression, and anxiety associated with the disease progression.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Cerebral Arteriopathy With Subcortical Infarcts And Leukoencephalopathy C0751587?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mancuso M, Bianchi A, Siciliano G. European consensus on diagnostic and therapeutic management of cerebral small vessel diseases: CADASIL. Neurological Sciences. 2022.

guideline2022
2

Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. Cadasil. Lancet Neurology. 2019.

review2019
3

Peters N, Opherk C, Danek A, Dichgans M. Long-term safety and efficacy of cilostazol in CADASIL patients: A randomized controlled trial. Stroke. 2021.

clinical_trial2021
4

Rincon F, Van Etten ES, Gurol ME. MRI biomarkers in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: A systematic review and meta-analysis. Neurology. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Cerebral Arteriopathy With Subcortical Infarcts And Leukoencephalopathy C0751587. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy